German Pharmaceutical company BioNTech said on Monday it aimed to start trialling a malaria vaccine by next year, using the same breakthrough mRNA technology at the core of Covid-19 vaccines to help fight the mosquito-borne disease, which kills more than 400,000 people every year.
READ MORE : [ Ссылка ]
Subscribe on our Youtube channel [ Ссылка ] and receive all the latest news from the continent.
Africanews is available in English and French.
Website : www.africanews.com
Facebook : [ Ссылка ]
Twitter : [ Ссылка ]
#AfNews
